SCHEDULE: Perceptive Advisors Divests KALA BIO Stake

Perceptive Advisors and related entities report 0% beneficial ownership in KALA BIO, Inc. common stock.

Summary

• Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. (collectively, the "Reporting Persons") have filed an amendment to their Schedule 13G.
• The Reporting Persons now beneficially own 0 shares of KALA BIO, Inc. Common Stock, representing 0% of the class.
• This filing indicates a complete divestment of their previous holdings in KALA BIO, Inc. common stock.
• The event requiring this filing occurred on September 30, 2025.

Sentiment

Score: 5

Explanation: The filing itself is a neutral, factual disclosure of a change in beneficial ownership. While the divestment by a significant institutional investor could be perceived negatively by the market, the document's content is purely informational without expressing positive or negative sentiment.

Negatives

• Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. no longer beneficially own any shares of KALA BIO, Inc. common stock, reporting 0% ownership.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from KALA BIO, Inc. or the Reporting Persons regarding the issuer's future performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing represents a standard disclosure by an institutional investor, Perceptive Advisors, regarding a change in its beneficial ownership in a publicly traded biotechnology company, KALA BIO, Inc. The complete divestment by a specialized life sciences fund like Perceptive Advisors could be interpreted by the market as a shift in their investment thesis or a re-evaluation of KALA BIO's prospects, potentially influencing other investors in the biotech sector.

Stakeholder Impact

• Shareholders of KALA BIO, Inc. may view the complete divestment by a prominent institutional investor like Perceptive Advisors as a negative signal, potentially leading to increased selling pressure or a re-evaluation of the company's stock.

Key Dates

Keywords

KALA BIO, Perceptive Advisors, Joseph Edelman, Schedule 13G, beneficial ownership, common stock, divestment